Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

OK BIOTECH ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   1.1% 1.3% 1.1% 0.9% 0.9% 0.6% 6.3% 6.3%   Credit score (0-100)   85 81 84 87 90 96 37 37   Credit rating   A A A A A AA BBB BBB   Credit limit (kDKK)   8,315.9 3,444.0 10,406.8 19,411.7 20,775.4 26,322.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -1,496 -2,245 -2,622 -4,095 -1,413 -2,191 0.0 0.0   EBITDA   -1,496 -2,387 -2,794 -4,268 -1,586 -2,382 0.0 0.0   EBIT   -1,496 -2,387 -2,794 -4,268 -1,586 -2,382 0.0 0.0   Pre-tax profit (PTP)   -5,559.4 26,412.6 11,834.1 33,197.1 -14,919.5 5,627.0 0.0 0.0   Net earnings   -4,413.7 19,969.3 10,103.7 28,266.6 -11,413.6 2,273.0 0.0 0.0   Pre-tax profit without non-rec. items   -5,559 26,413 11,834 33,197 -14,919 5,627 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   256,907 264,876 274,758 291,025 267,611 269,884 269,384 269,384   Interest-bearing liabilities   0.0 0.0 11.1 9,017 17,493 18,093 0.0 0.0   Balance sheet total (assets)   257,099 266,370 277,557 300,912 285,341 288,618 269,384 269,384   Net Debt   -252,970 -265,074 -275,872 -263,761 -228,495 -210,338 -269,384 -269,384     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -1,496 -2,245 -2,622 -4,095 -1,413 -2,191 0.0 0.0   Gross profit growth   14.3% -50.0% -16.8% -56.2% 65.5% -55.0% 0.0% 0.0%   Employees   0 1 0 1 1 1 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   257,099 266,370 277,557 300,912 285,341 288,618 269,384 269,384   Balance sheet change%   -2.2% 3.6% 4.2% 8.4% -5.2% 1.1% -6.7% 0.0%   Added value   -1,496.5 -2,387.4 -2,794.0 -4,268.0 -1,585.7 -2,382.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 106.3% 106.6% 104.2% 112.2% 108.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.2% 10.1% 8.0% 12.5% 7.5% 5.2% 0.0% 0.0%   ROI %   2.2% 10.1% 8.1% 12.6% 7.5% 5.2% 0.0% 0.0%   ROE %   -1.7% 7.7% 3.7% 10.0% -4.1% 0.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   99.9% 99.4% 99.0% 96.7% 93.8% 93.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   16,904.2% 11,103.2% 9,873.6% 6,179.9% 14,409.3% 8,829.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 3.1% 6.5% 6.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 178,687.9% 68.2% 279.1% 52.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1,329.0 177.6 98.8 313.7 346.7 134.6 0.0 0.0   Current Ratio   1,329.0 177.6 98.8 313.7 346.7 134.6 0.0 0.0   Cash and cash equivalent   252,969.6 265,074.3 275,883.2 272,777.7 245,987.9 228,431.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   7,313.2 4,710.4 240.7 8,030.3 16,035.8 15,364.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -2,387 0 -4,268 -1,586 -2,382 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -2,387 0 -4,268 -1,586 -2,382 0 0   EBIT / employee   0 -2,387 0 -4,268 -1,586 -2,382 0 0   Net earnings / employee   0 19,969 0 28,267 -11,414 2,273 0 0